Literature DB >> 17586867

Patterns of levodopa response in Parkinson's disease: a clinico-pathological study.

P A Kempster1, D R Williams, M Selikhova, J Holton, T Revesz, A J Lees.   

Abstract

Patients with Parkinson's disease who develop disabling levodopa-induced motor fluctuations have a stronger therapeutic response than those who experience a more modest but stable response. A difference in the histopathological lesion between the two groups might be responsible. Case records from 97 patients with pathologically proven Parkinson's disease were reviewed to determine the pattern of levodopa response. Pathological findings for fluctuating and non-fluctuating cases were compared. Patients with motor fluctuations had a younger age of onset and longer disease course (P < 0.001), although mean age at death was almost the same. Four milestones of advanced disease (frequent falls, visual hallucinations, cognitive disability and need for residential care) occurred at a similar time from death in each group; this interval was not proportionate to the disease duration. There were no significant differences in the severity or distribution of Lewy body or other pathologies. Irrespective of the pattern of levodopa response, patients reach a common pathological endpoint at a similar age, and the duration and manifestations of end-stage disease are alike. A non-linear or exponential time relationship may govern the late clinical and pathological progression of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586867     DOI: 10.1093/brain/awm142

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  Progression in ALS is not linear but is curvilinear.

Authors:  Paul H Gordon; Bin Cheng; Francois Salachas; Pierre-Francois Pradat; Gaelle Bruneteau; Philippe Corcia; Lucette Lacomblez; Vincent Meininger
Journal:  J Neurol       Date:  2010-06-08       Impact factor: 4.849

Review 2.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

Review 3.  Late-stage Parkinson disease.

Authors:  Miguel Coelho; Joaquim J Ferreira
Journal:  Nat Rev Neurol       Date:  2012-07-10       Impact factor: 42.937

4.  The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.

Authors:  Allison A Bay; Ariel R Hart; W Michael Caudle; Daniel M Corcos; Madeleine E Hackney
Journal:  J Neurol Sci       Date:  2018-12-04       Impact factor: 3.181

5.  Cerebellar Pathology in Early Onset and Late Onset Essential Tremor.

Authors:  Sheng-Han Kuo; Jie Wang; William J Tate; Ming-Kai Pan; Geoffrey C Kelly; Jesus Gutierrez; Etty P Cortes; Jean-Paul G Vonsattel; Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

6.  Tandem gait performance in essential tremor: clinical correlates and association with midline tremors.

Authors:  Elan D Louis; Eileen Rios; Ashwini K Rao
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 7.  Impulsivity and apathy in Parkinson's disease.

Authors:  Nihal Sinha; Sanjay Manohar; Masud Husain
Journal:  J Neuropsychol       Date:  2013-04-29       Impact factor: 2.864

Review 8.  Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

Authors:  Jens Volkmann; Christine Daniels; Karsten Witt
Journal:  Nat Rev Neurol       Date:  2010-08-03       Impact factor: 42.937

Review 9.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

10.  Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.

Authors:  Eduardo De Pablo-Fernández; Andrew J Lees; Janice L Holton; Thomas T Warner
Journal:  JAMA Neurol       Date:  2019-04-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.